Literature DB >> 23908477

Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.

Charles S Berenson1, Ragina L Kruzel, Ellana Eberhardt, Sanjay Sethi.   

Abstract

BACKGROUND: Alveolar macrophages in chronic obstructive pulmonary disease (COPD) have fundamental impairment of phagocytosis for nontypeable Haemophilus influenzae (NTHI). However, relative selectivity of dysfunctional phagocytosis among diverse respiratory pathogens: NTHI, Moraxella catarrhalis (MC), Streptococcus pneumoniae (SP), and nonbacterial particles, as well as the contribution of impaired phagocytosis to severity of COPD, has not been explored.
METHODS: Alveolar macrophages, obtained from nonsmokers (n = 20), COPD ex-smokers (n = 32), and COPD active smokers (n = 64), were incubated with labeled NTHI, MC, SP, and fluorescent microspheres. Phagocytosis was measured as intracellular percentages of each.
RESULTS: Alveolar macrophages of COPD ex-smokers and active smokers had impaired complement-independent phagocytosis of NTHI (P = .003) and MC (P = .0007) but not SP or microspheres. Nonetheless, complement-mediated phagocytosis was enhanced within each group only for SP. Defective phagocytosis was significantly greater for NTHI than for MC among COPD active smokers (P < .0001) and ex-smokers (P = .028). Moreover, severity of COPD (FEV1%predicted) correlated with impaired AM phagocytosis for NTHI (P = .0016) and MC (P = .01).
CONCLUSIONS: These studies delineate pathogen- and host-specific differences in defective alveolar macrophages phagocytosis of respiratory bacteria in COPD, further elucidating the immunologic basis for bacterial persistence in COPD and provide the first demonstration of association of impaired phagocytosis to severity of disease.

Entities:  

Keywords:  COPD; Moraxella catarrhalis; Streptococcus pneumoniae; alveolar macrophage; nontypeable Haemophilus influenzae; phagocytosis

Mesh:

Year:  2013        PMID: 23908477      PMCID: PMC3836465          DOI: 10.1093/infdis/jit400

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

Review 1.  Phagocytosis of microbes: complexity in action.

Authors:  David M Underhill; Adrian Ozinsky
Journal:  Annu Rev Immunol       Date:  2001-12-07       Impact factor: 28.527

2.  Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Authors:  Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

3.  Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.

Authors:  A T Hill; E J Campbell; S L Hill; D L Bayley; R A Stockley
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

4.  Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.

Authors:  Jie Li; Jennifer P Wang; Ionita Ghiran; Anna Cerny; Alexander J Szalai; David E Briles; Robert W Finberg
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

5.  Survival of nontypeable Haemophilus influenzae in macrophages.

Authors:  J E Craig; A Cliffe; K Garnett; N J High
Journal:  FEMS Microbiol Lett       Date:  2001-09-11       Impact factor: 2.742

Review 6.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

7.  Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease.

Authors:  P Bresser; T A Out; L van Alphen; H M Jansen; R Lutter
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

8.  Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins.

Authors:  S B Gordon; G R Irving; R A Lawson; M E Lee; R C Read
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.

Authors:  John C Phipps; David M Aronoff; Jeffrey L Curtis; Deepti Goel; Edmund O'Brien; Peter Mancuso
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

10.  Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke.

Authors:  Pau Martí-Lliteras; Verónica Regueiro; Pau Morey; Derek W Hood; Carles Saus; Jaume Sauleda; Alvar G N Agustí; José Antonio Bengoechea; Junkal Garmendia
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

View more
  53 in total

Review 1.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

Review 2.  Infections in "noninfectious" lung diseases.

Authors:  Meghan E Fitzpatrick; Sanjay Sethi; Charles L Daley; Prabir Ray; James M Beck; Matthew R Gingo
Journal:  Ann Am Thorac Soc       Date:  2014-08

Review 3.  Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions.

Authors:  William J Janssen; Adrianne L Stefanski; Bruce S Bochner; Christopher M Evans
Journal:  Eur Respir J       Date:  2016-09-01       Impact factor: 16.671

4.  Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency.

Authors:  Jana P Lovell; Christa S Zerbe; Kenneth N Olivier; Reginald J Claypool; Cathleen Frein; Victoria L Anderson; Alexandra F Freeman; Steven M Holland
Journal:  Ann Am Thorac Soc       Date:  2016-12

5.  Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.

Authors:  Begoña Euba; Javier Moleres; Cristina Viadas; Montserrat Barberán; Lucía Caballero; María-Jesús Grilló; José Antonio Bengoechea; Juan Pablo de-Torres; Josefina Liñares; José Leiva; Junkal Garmendia
Journal:  Antimicrob Agents Chemother       Date:  2015-02-23       Impact factor: 5.191

6.  Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathways.

Authors:  Charles V Rosadini; Sanjay Ram; Brian J Akerley
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

Review 7.  Immunodeficiency in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Sheling Xie; Kaifei Wang; Wei Zhang; Kun Xiao; Peng Yan; Yanqin Li; Wanxue He; Yuhan Zhang; Lixin Xie
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

8.  In vitro immunotoxicity assessment of culture-derived extracellular vesicles in human monocytes.

Authors:  Lucia E Rosas; Ola A Elgamal; Xiaokui Mo; Mitch A Phelps; Thomas D Schmittgen; Tracey L Papenfuss
Journal:  J Immunotoxicol       Date:  2016-04-14       Impact factor: 3.000

9.  Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists.

Authors:  Martin A Bewley; Richard C Budd; Eilise Ryan; Joby Cole; Paul Collini; Jennifer Marshall; Umme Kolsum; Gussie Beech; Richard D Emes; Irina Tcherniaeva; Guy A M Berbers; Sarah R Walmsley; Gavin Donaldson; Jadwiga A Wedzicha; Iain Kilty; William Rumsey; Yolanda Sanchez; Christopher E Brightling; Louise E Donnelly; Peter J Barnes; Dave Singh; Moira K B Whyte; David H Dockrell
Journal:  Am J Respir Crit Care Med       Date:  2018-09-15       Impact factor: 21.405

Review 10.  Respiratory risks from household air pollution in low and middle income countries.

Authors:  Stephen B Gordon; Nigel G Bruce; Jonathan Grigg; Patricia L Hibberd; Om P Kurmi; Kin-bong Hubert Lam; Kevin Mortimer; Kwaku Poku Asante; Kalpana Balakrishnan; John Balmes; Naor Bar-Zeev; Michael N Bates; Patrick N Breysse; Sonia Buist; Zhengming Chen; Deborah Havens; Darby Jack; Surinder Jindal; Haidong Kan; Sumi Mehta; Peter Moschovis; Luke Naeher; Archana Patel; Rogelio Perez-Padilla; Daniel Pope; Jamie Rylance; Sean Semple; William J Martin
Journal:  Lancet Respir Med       Date:  2014-09-02       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.